- Home
- ARVN vs SKYT Comparison
ARVN vs SKYT Comparison
Compare ARVN & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- SKYT
- Stock Information
- Founded
- ARVN 2015
- SKYT 1991
- Country
- ARVN United States
- SKYT United States
- Employees
- ARVN N/A
- SKYT N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- SKYT Semiconductors
- Sector
- ARVN Health Care
- SKYT Technology
- Exchange
- ARVN Nasdaq
- SKYT Nasdaq
- Market Cap
- ARVN 676.2M
- SKYT 578.1M
- IPO Year
- ARVN 2018
- SKYT 2021
- Fundamental
- Price
- ARVN $10.59
- SKYT $17.35
- Analyst Decision
- ARVN Buy
- SKYT Strong Buy
- Analyst Count
- ARVN 23
- SKYT 5
- Target Price
- ARVN $17.80
- SKYT $19.40
- AVG Volume (30 Days)
- ARVN 2.3M
- SKYT 2.4M
- Earning Date
- ARVN 11-05-2025
- SKYT 11-05-2025
- Dividend Yield
- ARVN N/A
- SKYT N/A
- EPS Growth
- ARVN N/A
- SKYT N/A
- EPS
- ARVN N/A
- SKYT 2.62
- Revenue
- ARVN $312,300,000.00
- SKYT $346,587,000.00
- Revenue This Year
- ARVN N/A
- SKYT $24.43
- Revenue Next Year
- ARVN N/A
- SKYT $44.21
- P/E Ratio
- ARVN N/A
- SKYT $6.58
- Revenue Growth
- ARVN 93.86
- SKYT 0.19
- 52 Week Low
- ARVN $5.90
- SKYT $5.67
- 52 Week High
- ARVN $27.00
- SKYT $24.23
- Technical
- Relative Strength Index (RSI)
- ARVN 59.44
- SKYT 49.14
- Support Level
- ARVN $9.27
- SKYT $14.13
- Resistance Level
- ARVN $11.51
- SKYT $24.23
- Average True Range (ATR)
- ARVN 0.53
- SKYT 2.11
- MACD
- ARVN 0.02
- SKYT 0.09
- Stochastic Oscillator
- ARVN 59.15
- SKYT 31.77
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SKYT SkyWater Technology Inc.
SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.